[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fzjvLKHqmbYNQCm0sOiftNEUm8WRynaOjnzNF-55qYLE":8,"$fTNwgeTg4f27Tyb4GGb127vaCrvkFUNW1te56hvza5zQ":55,"$fe22QzyIWfjvpANsJEeNR2Ppt2Ukorp6lZXrwtFmONFA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65782,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"前列腺恶性肿瘤放化疗药品使用全指南","","https://cdn.yishi-tong.com/console/store-5/I5iaI_HGc7nnyXg-sbbuuIPH0CXzYH0o.png","\u003Cdiv class=\"medpro-container\">\n  \u003Ch2 id=\"material_title\" class=\"medpro-main-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">前列腺恶性肿瘤放化疗药品使用全指南\u003C/h2>\n  \n  \u003Cdiv class=\"medpro-section medpro-bg1\">\n    \u003Ch2 class=\"medpro-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 服用放化疗药品：时间与方法须知 🕰️\u003C/h2>\n    \u003Cp>\n      药品的正确服用时间和方法，影响着放化疗效果和不良反应。大部分用于本类治疗的口服化疗药物（如多西他赛、阿比特龙）通常要求空腹服用，比如阿比特龙应在餐前至少1小时或餐后2小时服用。部分药品需配合大量温水吞服，整个服药过程尽量固定在每天同一时间，帮助身体保持稳定的药物浓度。静脉用药应严格遵循医嘱，由医护人员操作，不可自行加快或减慢速度。\n    \u003C/p>\n    \u003Cdiv class=\"medpro-tip\">\n      正确做法：按照药品说明书或医生指导的具体时间和服用方式进行，不可随意调整。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"medpro-section medpro-bg2\">\n    \u003Ch2 class=\"medpro-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型选择及用药技巧💊\u003C/h2>\n    \u003Cp>\n      放化疗药品有多种剂型，包括片剂、注射剂、胶囊等。口服剂型如度他雄胺、阿比特龙等，需整片吞服，不能掰碎或嚼碎。注射类药物（如多西他赛）只能由专业医护人员操作，家庭中不可自行注射。肠溶片等特殊剂型，应避免与含酒精饮品合用，以免破坏剂型设计导致药效异常。此外，服药时需喝足够的水，有助于药品在体内分布和减轻胃肠道负担。\n    \u003C/p>\n    \u003Cdiv class=\"medpro-tip\">\n      特别提醒：剂型不可随意更换或分割，任何调整必须在医生指导下进行。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"medpro-section medpro-bg3\">\n    \u003Ch2 class=\"medpro-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药物相互作用不可忽视⚡\u003C/h2>\n    \u003Cp>\n      部分药品对药物酶（如CYP3A4）有影响，容易与其他药物（如部分降压药、抗凝药、抗癫痫药）产生相互作用。以阿比特龙为例，服用同时使用抗癫痫药可能导致体内药物浓度不稳定。多西他赛与强效CYP3A4抑制剂合用时，毒性风险增加。\n    \u003C/p>\n    \u003Cdiv class=\"medpro-tip\">\n      正确做法：用药期间如需加用或更换其他药物，一定要提前咨询医师或药师，不可自行组合用药。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"medpro-section medpro-bg4\">\n    \u003Ch2 class=\"medpro-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 用药剂量与疗程调整须知📏\u003C/h2>\n    \u003Cp>\n      放化疗药品的剂量由医生根据个体差异和实际效果严格制定。阿比特龙推荐每日1000mg，须与泼尼松联合；多西他赛按体重和体表面积计算剂量。剂量更改通常基于耐受性、不良反应及实验室数据。老年人和肝肾功能减退者需调整剂量，避免药物蓄积和毒副反应。\n    \u003C/p>\n    \u003Cdiv class=\"medpro-tip\">\n      正确做法：严格按照医师规定的剂量和周期用药，不可自作主张减量、停药或提前终止。\n    \u003C/div>\n    \u003Cp>\n      \u003Cspan class=\"medpro-case\">案例：\u003C/span>一位77岁男性服用阿比特龙联合泼尼松，遵医嘱调整剂量，顺利完成疗程，未出现严重不良反应。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"medpro-section medpro-bg5\">\n    \u003Ch2 class=\"medpro-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 主要不良反应及处理要点⚠️\u003C/h2>\n    \u003Cp>\n      药品不良反应包括消化道反应（如恶心、食欲减退）、血液系统反应（如白细胞减少）、肝功能异常、水肿、高血压等。例如，阿比特龙常伴随低钾血症、多西他赛可能引发骨髓抑制。出现轻微不适时可暂时观察，如恶心明显建议分次服药并多饮水。\n    \u003C/p>\n    \u003Cp>\n      出现严重不良反应如持续高热、出血、黄疸等应立即告知医生处理，不可自行用药或停药。\n    \u003C/p>\n    \u003Cdiv class=\"medpro-tip\">\n      处理方法：出现不适需及时就医，极严重时须到急诊科处理。\n    \u003C/div>\n    \u003Cp>\n      \u003Cspan class=\"medpro-case\">案例：\u003C/span>临床中有患者因合并用药，出现转氨酶升高，经医师指导停药及调整方案后，肝功能迅速恢复。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"medpro-section medpro-bg6\">\n    \u003Ch2 class=\"medpro-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 特殊人群安全用药指南👴\u003C/h2>\n    \u003Cp>\n      年龄大于65岁的患者，尤其是老年人，常因肝肾功能减退或合并疾病需调整药物剂量。对孕妇和哺乳期女性（用于相关适应症时），均不建议使用本类药品。肝肾功能异常、糖尿病患者、心血管疾病史者，在医生指导下调整并密切监测用药反应。\n    \u003C/p>\n    \u003Cdiv class=\"medpro-tip\">\n      正确做法：老年人每用一种药品均须在医生指导下慎重开始，并密切随访检测相关指标。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"medpro-section medpro-bg7\">\n    \u003Ch2 class=\"medpro-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存条件细节须知🧊\u003C/h2>\n    \u003Cp>\n      放化疗药品通常需避光、密封并储存在25℃以下的干燥处。有些针剂需冷藏，不可冷冻。药品开瓶后应尽快使用，剩余药液需根据说明书规定处理。过期药品须送至药品回收或医疗机构，不可随意丢弃或自行焚烧。\n    \u003C/p>\n    \u003Cdiv class=\"medpro-tip\">\n      正确做法：药品务必妥善存放于儿童无法接触的地方，并定期检查药品有效期。\n    \u003C/div>\n    \u003Cp>\n      \u003Cspan class=\"medpro-case\">案例：\u003C/span>一位患者因将阿比特龙片放于卫生间潮湿环境，导致药片受潮变色，停用后更换新药无影响。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"medpro-section medpro-bg8\">\n    \u003Ch2 class=\"medpro-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服与过量应急管理⏰\u003C/h2>\n    \u003Cp>\n      不小心漏服药片，可在想起时尽快补上，但距离下次服药时间过近则无需补服。勿为补服而擅自加量。若出现过量服用，如明显不适、意识混乱、恶心呕吐等现象，应立即就医。\n    \u003C/p>\n    \u003Cdiv class=\"medpro-tip\">\n      正确做法：若不慎漏服，遵循“补得早，不补迟”原则；怀疑过量时立即到医疗机构救治。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"medpro-section medpro-bg9\">\n    \u003Ch2 class=\"medpro-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 药品优势与理性用药建议🛡️\u003C/h2>\n    \u003Cp>\n      放化疗药品具有靶向性强、组合作用灵活等优势。多数药物通过阻断雄激素生物合成、抑制肿瘤细胞分裂实现作用，有助于提高患者生活质量。为规避风险，务必遵医嘱，同时密切配合血常规和肝肾功能监测。定期复查是保障安全用药和疗效优化的重要措施。合理使用药品，方能最大化获益并减少风险。\n    \u003C/p>\n    \u003Cdiv class=\"medpro-tip\">\n      再次强调：不懂勿自行更改用药方案，任何用药问题请第一时间询问主诊医生或药师。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"medpro-section medpro-refbg\">\n    \u003Ch2 class=\"medpro-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col class=\"medpro-ref-list\">\n      \u003Cli>\n        Attard, G., Reid, A. H. M., Yap, T. A., et al. (2009). Phase I clinical trial of a selective CYP17 inhibitor in castration-resistant prostate cancer: Clinical responses and pharmacokinetics. \u003Cem>Journal of Clinical Oncology\u003C/em>, 27(23), 3742-3748. https://doi.org/10.1200/JCO.2008.20.2174\n      \u003C/li>\n      \u003Cli>\n        de Bono, J. S., Oudard, S., Ozguroglu, M., et al. (2010). Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial. \u003Cem>The Lancet\u003C/em>, 376(9747), 1147-1154. https://doi.org/10.1016/S0140-6736(10)61389-X\n      \u003C/li>\n      \u003Cli>\n        Scher, H. I., Sawyers, C. L. (2005). Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis. \u003Cem>Journal of Clinical Oncology\u003C/em>, 23(32), 8253-8261. https://doi.org/10.1200/JCO.2005.03.4777\n      \u003C/li>\n      \u003Cli>\n        de Bono, J. S., Logothetis, C. J., Molina, A., et al. (2011). Abiraterone and increased survival in metastatic prostate cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 364(21), 1995-2005. https://doi.org/10.1056/NEJMoa1014618\n      \u003C/li>\n      \u003Cli>\n        Eisenberger, M., Hardy-Bessard, A. C., Kim, C. S., et al. (2015). Biomarkers of efficacy and safety of docetaxel chemotherapy in men with metastatic castration-resistant prostate cancer. \u003Cem>British Journal of Cancer\u003C/em>, 113(6), 823-831. https://doi.org/10.1038/bjc.2015.282\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.medpro-container {\n  background-color: #fafeff;\n  padding: 38px 10% 44px 10%;\n  box-sizing: border-box;\n  font-family: 'Segoe UI', 'Microsoft YaHei', Arial, sans-serif;\n  color: #323c48;\n  max-width: 960px;\n  min-width: 330px;\n  margin: 0 auto;\n  border-radius: 26px;\n  box-shadow: 0 4px 22px rgba(34, 60, 95, 0.11);\n}\n.medpro-main-title {\n  font-size: 2.2em;\n  font-weight: 700;\n  text-align: center;\n  color: #1a1942;\n  letter-spacing: 1.2px;\n  margin-bottom: 32px;\n  margin-top: 0;\n}\n.medpro-section {\n  margin-bottom: 32px;\n  border-radius: 14px;\n  padding: 32px 32px 16px 32px;\n  box-sizing: border-box;\n  position: relative;\n  background-color: #fff;\n  box-shadow: 0 2px 12px rgba(70, 102, 164, 0.06);\n}\n.medpro-bg1 {\n  background: linear-gradient(100deg, #e3f8f6 92%, #c2e4ff 100%);\n}\n.medpro-bg2 {\n  background: linear-gradient(98deg, #f2fbfa 86%, #f0eaff 100%);\n}\n.medpro-bg3 {\n  background: linear-gradient(94deg, #e9faf3 90%, #d5eefd 100%);\n}\n.medpro-bg4 {\n  background: linear-gradient(90deg, #f7f6fa 90%, #f6f0fa 100%);\n}\n.medpro-bg5 {\n  background: linear-gradient(97deg, #f0f2fa 89%, #ffecec 100%);\n}\n.medpro-bg6 {\n  background: linear-gradient(98deg, #fafaf7 80%, #e8f2e4 100%);\n}\n.medpro-bg7 {\n  background: linear-gradient(98deg, #f9faf8 85%, #eaf5ff 100%);\n}\n.medpro-bg8 {\n  background: linear-gradient(96deg, #eeeef9 90%, #eaf8fa 100%);\n}\n.medpro-bg9 {\n  background: linear-gradient(100deg, #e3f6fa 85%, #fdffec 100%);\n}\n.medpro-refbg {\n  background: linear-gradient(120deg, #fafcff 86%, #f6f5fb 100%);\n  padding-top: 26px;\n  padding-bottom: 20px;\n  margin-top: 48px;\n}\n.medpro-h2 {\n  font-size: 1.32em;\n  font-weight: 600;\n  color: #244a72;\n  margin-bottom: 18px;\n  border-left: 5px solid #3cbbc9;\n  padding-left: 12px;\n  letter-spacing: 1px;\n  background: rgba(230, 255, 251, 0.38);\n  border-radius: 8px;\n  display: inline-block;\n}\n.medpro-tip {\n  margin: 14px 0 0 0;\n  background: linear-gradient(98deg, #e7f8fc 82%, #d0e7ff 100%);\n  border-left: 4px solid #70bacd;\n  padding: 10px 18px;\n  border-radius: 8px;\n  color: #236e83;\n  font-weight: 500;\n  line-height: 1.7;\n}\n.medpro-case {\n  background: #f6f3e7;\n  border-left: 3px solid #ffda8a;\n  padding: 4px 8px 4px 12px;\n  border-radius: 3px;\n  margin-right: 4px;\n  color: #b28621;\n  font-size: 1em;\n  font-weight: 500;\n  display: inline-block;\n}\n.medpro-ref-list {\n  margin-top: 16px;\n  margin-bottom: 0;\n  padding-left: 22px;\n  font-size: 0.98em;\n  color: #334b65;\n}\n.medpro-ref-list li {\n  margin-bottom: 8px;\n  line-height: 1.7;\n}\n@media (max-width: 700px) {\n  .medpro-container {\n    padding: 16px 2% 20px 2%;\n    border-radius: 0;\n  }\n  .medpro-section {\n    padding: 18px 9px 9px 13px;\n  }\n  .medpro-h2 {\n    font-size: 1.12em;\n    padding-left: 8px;\n    border-left-width: 3px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"medpro-container\">\n  \u003Ch2 id=\"material_title\" class=\"medpro-main-title\" style=\"color: rgb",506,"2025-09-05 15:39:06","前列腺恶性肿瘤, 放化疗药品, 药物使用指南, 剂量调整, 不良反应","本文提供前列腺恶性肿瘤放化疗药品的详细使用指南，确保您正确服用药物，优化疗效，减少不良反应。适合每位患者及其家属阅读！","2025-09-09 17:29:56",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]